C-aryl glucoside SGLT2 inhibitors
- 专利权人:
- AstraZeneca AB
- 发明人:
- 申请号：
- NO2014017
- 公开号：
- NO2014017I1
- 申请日:
- 2014.07.09
- 申请国别(地区):
- NO
- 年份:
- 2014
- 代理人:
- 摘要：
- An SGLT2 inhibiting compound is provided having the formula A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above compound alone or in combination with another antidiabetic agent or other therapeutic agent.
- 来源网站：
- 中国工程科技知识中心
